Skip to main content
. 2021 Jul 10;61(2):217–221. doi: 10.2169/internalmedicine.7485-21

Figure 3.

Figure 3.

Clinical course of the patient. On initiation of olaparib administration, the number of lymphocytes began to gradually decrease.